Incyte Corporation Stock Price and Value Analysis

Should you buy Incyte Corporation stock? (NasdaqGS:INCY). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This company is making money at a modest rate.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the INCY Numbers

INCY Price
(Incyte Corporation stock price per share)
[?] INCY Fair Price
(based on intrinsic value)
[?] INCY Safety Price (based on a variable margin of safety) $6.59
[?] PE Ratio versus Sector 20% lower than other Healthcare stocks
[?] PE Ratio versus Industry 71% lower than other Biotechnology stocks
[?] Cash Yield 0.72%
[?] Free Cash Flow Jitter 115%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 8,189,281 shares shorted. With 184,339,389 shares available for purchase and an average trading volume over the past 10 trading days of 1,429,040, it would take at least 5.731 days for all of the short holders to cover their shorts.

Is Incyte Corporation Stock on Sale?

We believe that Incyte Corporation may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Incyte Corporation looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy INCY Stock?

Does Incyte Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.